Search - tctmd.com

Displaying 821 - 840 of 1583

Sort: Relevancy | Date

News Conference News ESC 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Michael O'Riordan

September 01, 2020

News Conference News ESC 2020

Dapagliflozin Wins in Patients With CKD

Todd Neale

August 31, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Conference News ESC 2020

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

Shelley Wood

August 31, 2020

News Conference News ESC 2020

Trimetazidine Safe but Not Protective Long-term After PCI

Caitlin E. Cox

August 30, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Daily News

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Yael L. Maxwell

August 27, 2020

News Daily News

Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin

Michael O'Riordan

August 25, 2020

News Daily News

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Michael O'Riordan

August 20, 2020

News Daily News

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Yael L. Maxwell

August 19, 2020

News Daily News

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Michael O'Riordan

August 14, 2020

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

Yael L. Maxwell

August 06, 2020

News Daily News

Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests

Todd Neale

August 03, 2020

News Daily News

NSAIDs Boost CV, Bleeding Risks in Post-MI Patients

Todd Neale

July 28, 2020

News Daily News

Thrombus Burden Greater in STEMI Patients With COVID-19

Michael O'Riordan

July 20, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

Advertisement

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Dapagliflozin Wins in Patients With CKD

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

Trimetazidine Safe but Not Protective Long-term After PCI

TCTMD’s Top 10 Most Popular Stories for August 2020

Icosapent Ethyl Could Prevent Thousands of CVD Events if Used as Indicated

Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Could Statins Curb Fatal or Severe COVID-19? Some Clues

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests

NSAIDs Boost CV, Bleeding Risks in Post-MI Patients

Thrombus Burden Greater in STEMI Patients With COVID-19

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content